Your browser doesn't support javascript.
loading
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update.
Zhang, Xiao-Hui; Chen, Jing; Han, Ming-Zhe; Huang, He; Jiang, Er-Lie; Jiang, Ming; Lai, Yong-Rong; Liu, Dai-Hong; Liu, Qi-Fa; Liu, Ting; Ren, Han-Yun; Song, Yong-Ping; Sun, Zi-Min; Tang, Xiao-Wen; Wang, Jian-Min; Wu, De-Pei; Xu, Lan-Ping; Zhang, Xi; Zhou, Dao-Bin; Huang, Xiao-Jun.
Afiliação
  • Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Chen J; Shanghai Children's Medical Center, Shanghai, China.
  • Han MZ; Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Hematologic Disease, Tianjin, China.
  • Huang H; First Affiliated Hospital of Zhejiang University, Hangzhou, China.
  • Jiang EL; Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Hematologic Disease, Tianjin, China.
  • Jiang M; The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
  • Lai YR; The First Affiliated Hospital of Guangxi Medical University, Guilin, China.
  • Liu DH; General Hospital of PLA (People's Liberation Army of China), Beijing, China.
  • Liu QF; Nanfang Hospital of Southern Medical University, Guangzhou, China.
  • Liu T; West China Hospital, Sichuan University, Chengdu, China.
  • Ren HY; Peking University First Hospital, Beijing, China.
  • Song YP; Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Sun ZM; The First Affiliated Hospital of University of Science and Technology of China, Hefei, China.
  • Tang XW; The First Affiliated Hospital of Soochow Hospital, National Clinical Research Center for Hematologic Disease, Suzhou, China.
  • Wang JM; Changhai Hospital of Shanghai, Naval Medical University, Shanghai, China.
  • Wu DP; The First Affiliated Hospital of Soochow Hospital, National Clinical Research Center for Hematologic Disease, Suzhou, China.
  • Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Zhang X; Xinqiao Hospital, Army Military Medical University, Chongqing, China.
  • Zhou DB; Peking Union Medical College Hospital, Beijing, China.
  • Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China. xjhrm@medmail.com.cn.
J Hematol Oncol ; 14(1): 145, 2021 09 15.
Article em En | MEDLINE | ID: mdl-34526099

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Seleção do Doador Tipo de estudo: Guideline Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Seleção do Doador Tipo de estudo: Guideline Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article